All treatments
Treatment
Vemlidy 25 mg film-coated tablets clinical trials
2 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic exploratory (Phase II)
Dosing EvaLuation of Tenofovir Alafenamide on Epstein-Barr Virus (The DELTA-EBV study)
This study is looking at a new way to treat Epstein-Barr virus (EBV) by testing a medicine called Vemlidy. Researchers want to see if it's safe and how it affects the virus in people's bodies, especially by checking side effects and changes in the virus in saliva.
For: Epstein-Barr virus infectionNorway - Ongoing, recruitingTherapeutic exploratory (Phase II)
Tenofovir Alafenamide Fumarate and Epstein-Barr virus activity in people with MS – The TAF-MS study
This study, called TAF-MS, is looking into how a medicine called Tenofovir Alafenamide Fumarate (TAF) affects the Epstein-Barr virus (EBV) in people with Multiple Sclerosis (MS). Researchers want to see if this treatment can help reduce EBV activity, which may be linked to MS.
For: Multiple sclerosisNorway